echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The State Food and Drug Administration requests revision of propranolol tablet instructions

    The State Food and Drug Administration requests revision of propranolol tablet instructions

    • Last Update: 2021-07-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network, July 27th.
    Recently, the State Food and Drug Administration issued an announcement clarified that based on the results of the adverse drug reaction assessment, it has decided to make unified revisions to the instructions of propranolol tablets [Precautions] and other items
    .
    It is worth noting that there are differences in the opinions on the revision of the instructions for products that have passed the quality and efficacy consistency evaluation of generic drugs
    .
     
    For propranolol tablets that have passed the consistency evaluation, the instructions [Precautions] should be added under "Article 9 of this product with caution in the following situations: children (can cause severe hypoglycemia with cramps and lethargy)" "There are the following tips in the instructions of similar foreign drugs
    .
    " For propranolol tablets that have not passed the consistency evaluation, the following content should be added in the item of "Precautions": "Children should use this product with caution, and there are the following tips on children's medication in similar foreign drug inserts"
    .
    The contents mentioned are "Before starting propranolol treatment, it is necessary to screen for the risks related to the use of propranolol, analyze the medical history and carry out the corresponding clinical examination.
    " "If there is a lower respiratory tract infection with breathing difficulties and wheezing, Then the drug should be temporarily stopped and seek medical attention in time” and other 5 items
    .
     
    The announcement requires that the holders of relevant drug marketing authorizations should revise the instructions in accordance with the corresponding requirements in accordance with the " Drug Registration Management Measures" and other relevant regulations, and report to the provincial drug regulatory authority for record before October 14, 2021
    .
    If the revised content involves the drug label, it should be revised together, and other contents of the insert sheet and label should be consistent with the original approved content
    .
    The holder of the drug marketing authorization shall replace the instructions and labels of the drugs that have been shipped out of the factory within 9 months after filing
    .
      Medical Network, July 27th.
    Recently, the State Food and Drug Administration issued an announcement clarified that based on the results of the adverse drug reaction assessment, it has decided to make unified revisions to the instructions of propranolol tablets [Precautions] and other items
    .
    It is worth noting that there are differences in the opinions on the revision of the instructions for products that have passed the quality and efficacy consistency evaluation of generic drugs
    .
     
      For propranolol tablets that have passed the consistency evaluation, the instructions [Precautions] should be added under "Article 9 of this product with caution in the following situations: children (can cause severe hypoglycemia with cramps and lethargy)" "There are the following tips in the instructions of similar foreign drugs
    .
    " For propranolol tablets that have not passed the consistency evaluation, the following content should be added in the item of "Precautions": "Children should use this product with caution, and there are the following tips on children's medication in similar foreign drug inserts"
    .
    The contents mentioned are "Before starting propranolol treatment, it is necessary to screen for the risks related to the use of propranolol, analyze the medical history and carry out the corresponding clinical examination.
    " "If there is a lower respiratory tract infection with breathing difficulties and wheezing, Then the drug should be temporarily stopped and seek medical attention in time” and other 5 items
    .
     
      The announcement requires that the holders of relevant drug marketing authorizations should revise the instructions in accordance with the corresponding requirements in accordance with the " Drug Registration Management Measures" and other relevant regulations, and report to the provincial drug regulatory authority for record before October 14, 2021
    .
    If the revised content involves the drug label, it should be revised together, and other contents of the insert sheet and label should be consistent with the original approved content
    .
    The holder of the drug marketing authorization shall replace the instructions and labels of the drugs that have been shipped out of the factory within 9 months after filing
    .
      Medical Network, July 27th.
    Recently, the State Food and Drug Administration issued an announcement clarified that based on the results of the adverse drug reaction assessment, it has decided to make unified revisions to the instructions of propranolol tablets [Precautions] and other items
    .
    It is worth noting that there are differences in the opinions on the revision of the instructions for products that have passed the quality and efficacy consistency evaluation of generic drugs
    .
     
      For propranolol tablets that have passed the consistency evaluation, the instructions [Precautions] should be added under "Article 9 of this product with caution in the following situations: children (can cause severe hypoglycemia with cramps and lethargy)" "There are the following tips in the instructions of similar foreign drugs
    .
    " For propranolol tablets that have not passed the consistency evaluation, the following content should be added in the item of "Precautions": "Children should use this product with caution, and there are the following tips on children's medication in similar foreign drug inserts"
    .
    The contents mentioned are "Before starting propranolol treatment, it is necessary to screen for the risks related to the use of propranolol, analyze the medical history and carry out the corresponding clinical examination.
    " "If there is a lower respiratory tract infection with breathing difficulties and wheezing, Then the drug should be temporarily stopped and seek medical attention in time” and other 5 items
    .
    Child, child, kid
     
      The announcement requires that the holders of relevant drug marketing authorizations should revise the instructions in accordance with the corresponding requirements in accordance with the " Drug Registration Management Measures" and other relevant regulations, and report to the provincial drug regulatory authority for record before October 14, 2021
    .
    If the revised content involves the drug label, it should be revised together, and other contents of the insert sheet and label should be consistent with the original approved content
    .
    The holder of the drug marketing authorization shall replace the instructions and labels of the drugs that have been shipped out of the factory within 9 months after filing
    .
    Drugs Drugs Drugs Drug Registration Drug Registration Drug Registration
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.